All atropine Articles

Low-Dose Atropine: Where Are We Now?

Get an in-depth look at the current state of low-dose atropine for myopia management. March 16, 2026 By Huy Tran and Nguyen...

798

Choroidal Thickness: A Biomarker for Monitoring Myopia Intervention Effectiveness

March 16, 2026 By John Nguyen, BOptom How quickly can we tell if a myopia treatment is working? For practitioners relying on...

125

Sydnexis Shares Latest STAR Trial Data at AAPOS 2026

March 23, 2026 DEL MAR, Calif. — At the 2026 American Association for Pediatric Ophthalmology and Strabismus (AAPOS) annual meeting, Sydnexis shared...

368

Pupil Area and the Efficacy of Peripheral Defocus Spectacle Lenses in Myopia Control

March 9, 2026 By Kevin Chan, OD, MS, FAAO, IACMM Optical ‘Defocus’ and Pupillary Dynamics – Clinical Background For years, the premise...

Dr. Damaris Raymondi with a young patient from her practice

430

Practice Profiles

How Simplicity And Community Affect Access To Care

February 13, 2026 By Damaris Raymondi, OD, FAAO For me, serving my community means providing the best possible eye care. I love...

216

Predictive Value of Past Myopia Progression for Future Progression

February 1, 2026 By Kevin Chan, OD, MS, FAAO, IACMM The soaring trend of prevalence of myopia among children is no longer...

473

Integrating Myopia Care Into Everyday Primary Practice

January 15, 2026 By Kimberly Orr, OD I came into my associate role thinking of myself as a primary care clinician rather...

532

How To Create An ‘All In’ Myopia Management Practice

Take your practice to the next level with these expert tips. December 2, 2025 By Dr. Sami Khaldieh, OD, IACMM As myopia...

1.4K

Is Treatment Needed for Accommodative-Convergence Issues Before Myopia Control?

December 2, 2025 By Rohit Dhakal BOptom, PhD; Safal Khanal, OD, PhD, FAAO Interest in accommodative–convergence function in myopia is largely driven...

537

Editor’s Perspective

When the Data Say Yes but the FDA Says No

The recent FDA decision on SYD-101 has implications on the eye care industry. November 17, 2025 Ashley Wallace Tucker, OD, FAAO, FSLS...

823

The Role of Astigmatism in Myopia Development, Progression and Control

November 17, 2025 By Ashley Wallace Tucker, OD, FAAO, FSLS This scoping review investigates how astigmatism influences the onset, progression and control...

910

Response of Accommodation and Vergence Systems to Low Dose Atropine

November 1, 2025 By Kevin Chan, OD, MS, FAAO, IACMM The use of low-dose atropine on the accommodation and the vergence system...

1.1K

Sydnexis Partner Santen Wins U.K. Approval for Ryjunea to Slow Childhood Myopia

November 6, 2025 DEL MAR, Calif. — Sydnexis‘ partner Santen has announced that the U.K. Medicines and Healthcare products Regulatory Agency (MHRA)...

495

Sydnexis Shares Pivotal Data from STAR Trial at AMCP Nexus

November 4, 2025 DEL MAR, Calif. — At the Academy of Managed Care Pharmacy (AMCP) Nexus 2025, Sydnexis shared topline results from...

619

FDA Delays Approval of Sydnexis’ SYD-101 for Myopia, Asking for More Evidence

October 24, 2025 DEL MAR, Calif. — The U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) to...

777

Dr. Khanal, UAB Optometry Enter $25 Million NIH-Funded Study on Myopia

October 23, 2025 BIRMINGHAM, Ala. — The University of Alabama at Birmingham (UAB) School of Optometry, led by Safal Khanal, OD, PhD,...

1.2K

0.01% Atropine Eye Drops in Children With Myopia and Intermittent Exotropia

October 1, 2025 By Nguyen Nguyen, MD, and Huy Tran, MD, PhD The underlying mechanism for myopia progression is uncertain. However, evidence...

1.2K

Managing Juvenile-Onset Myopia When an Optical Biometer is Unavailable

With our expanding knowledge of juvenile-onset myopia, the accurate diagnosis and treatment of the disease is paramount to reduce the burden of...

573

Is Tapering Myopia Management Therapy Necessary Before Discontinuation?

September 1, 2025 By Dr. Gareth Lingham Morth Clinicians now have access to a range of myopia control therapies that have been...

857

Impact of Low-Dose Atropine on Pupillary Diameter and Accommodative Amplitude

August 1, 2025 By Durgasri Jaisankar, PhD, Research Scientist at Brien Holden Vision Institute Low-dose atropine eye drops have demonstrated to be...

684

What’s Holding You Back? Addressing the Barriers in Implementing Myopia Management

Have you been dragging your feet or are you stalled in implementing myopia management? If so, you’re not alone. Jobson Optical Research...

579

A Call to Action: Embrace Myopia Management as a Public Health Imperative

“The start is what stops most people.” –Don Shula Overall, only 23% of myopic patients aged 18 and under are receiving some...

808